SanBio sanbio.com


Public list: Pharma Startups (6570) Clinical Trials Tech (201) Neuroscience Startups (947)

SanBio is a regenerative medicine company with cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, was built for treatment of chronic motor impairments resulting from stroke.

SanBio is a regenerative medicine company with cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, was built for treatment of chronic motor impairments resulting from stroke.

Company (Alive / Active)

Phone:

Fax:

St. Luke Tower 28F
8-1 Akashi-cho, Chuo-ku
Tokyo, 104-0044
Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SanBio $20M Sep 10, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SanBio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Extracellular matrix from pluripotent cells Dec 03, 2008 Jul 07, 2020 Patent
Extracellular matrix from pluripotent cells Jan 12, 2018 May 19, 2020 Patent
Methods and compositions for modulation of migration of neurogenic cells Feb 26, 2019 Apr 21, 2020 Patent
Methods and compositions for modulating peripheral immune function Apr 21, 2017 Jan 28, 2020 Patent
Extracellular matrix from pluripotent cells Apr 04, 2018 Nov 12, 2019 Patent
See all 43 patents